相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
Jianglian She et al.
FRONTIERS IN PHARMACOLOGY (2022)
A practical guide to large-scale docking
Brian J. Bender et al.
NATURE PROTOCOLS (2021)
Impact of natural products on the cholesterol transporter ABCA1
Dongdong Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Picroside II protects against cholestatic liver injury possibly through activation of farnesoid X receptor
Tingting Li et al.
PHYTOMEDICINE (2020)
Bile Acids and FXR: Novel Targets for Liver Diseases
Mary Stofan et al.
FRONTIERS IN MEDICINE (2020)
FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury
Bo Kong et al.
DIGESTIVE AND LIVER DISEASE (2019)
Cholestatic liver disease results increased production of reactive aldehydes and an atypical periportal hepatic antioxidant response
Colin T. Shearn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR
Weili Zheng et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro
Xiaoguang Gao et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Ligand binding and heterodimerization with retinoid X receptor alpha (RXR alpha) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding
Na Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and Therapeutic Advances
Vania Cruz-Ramon et al.
ANNALS OF HEPATOLOGY (2017)
Obeticholic acid for the treatment of primary biliary cholangitis
Ahmad H. Ali et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Mutations in the nuclear bile acid receptor FXR cause progressive familial intrahepatic cholestasis
Natalia Gomez-Ospina et al.
NATURE COMMUNICATIONS (2016)
Fatty liver diseases, bile acids, and FXR
Yan Zhu et al.
ACTA PHARMACEUTICA SINICA B (2016)
Fibrates and cholestasis
Nisanne S. Ghonem et al.
HEPATOLOGY (2015)
Bile acid nuclear receptor FXR and digestive system diseases
Lili Ding et al.
ACTA PHARMACEUTICA SINICA B (2015)
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
Jinlong Ru et al.
JOURNAL OF CHEMINFORMATICS (2014)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Signaling by Nuclear Receptors
Richard Sever et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice
Bo Kong et al.
HEPATOLOGY (2012)
Farnesoid X Receptor Agonist for the Treatment of Liver and Metabolic Disorders: Focus on 6-ethyl-CDCA
S. Fiorucci et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2011)
TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
Calvin Yu-Chian Chen
PLOS ONE (2011)
Structural and functional insights into nuclear receptor signaling
Lihua Jin et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Bile salts and cholestasis
Lucas Maillette de Buy Wenniger et al.
DIGESTIVE AND LIVER DISEASE (2010)
Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy
Saskia W. C. Van Mil et al.
GASTROENTEROLOGY (2007)
分享论文
